A Clinical Research About CD70-targeted CAR-NKT Cells Therapy Advanced Malignant Solid Tumors - Trial NCT06394622
Access comprehensive clinical trial information for NCT06394622 through Pure Global AI's free database. This Phase 1 trial is sponsored by Fudan University and is currently Recruiting. The study focuses on Solid Tumor. Target enrollment is 12 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Cyclophosphamide + Fludarabine + Infusion of CAR-NKT Cells
Interventional
combination product
Sponsor & Location
Fudan University
Timeline & Enrollment
Phase 1
Apr 11, 2024
Jun 28, 2026
Primary Outcome
ORR of CD70 CAR-NKT cell dynamics
Summary
This is a phase I, open-label, single-arm study conducted to evaluate the efficacy, safety
 and PK of CGC729 in the treatment of advanced malignant solid tumors.
 
 Condition or disease:advanced malignant solid tumors. Intervention/treatment:Biological: CD70
 CAR-NKT cells. Phase:I
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06394622
Non-Device Trial